371 related articles for article (PubMed ID: 26798943)
1. Golimumab for treatment of axial spondyloarthritis.
Rios Rodriguez V; Poddubnyy D
Immunotherapy; 2016 Feb; 8(2):107-15. PubMed ID: 26798943
[TBL] [Abstract][Full Text] [Related]
2. An appraisal of golimumab in the treatment of severe, active nonradiographic axial spondyloarthritis.
Paccou J; Flipo RM
Drug Des Devel Ther; 2016; 10():2255-62. PubMed ID: 27468228
[TBL] [Abstract][Full Text] [Related]
3. Golimumab for the treatment of axial spondyloarthritis.
Gelfer G; Perry L; Deodhar A
Expert Rev Clin Immunol; 2016; 12(1):9-18. PubMed ID: 26523483
[TBL] [Abstract][Full Text] [Related]
4. Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials.
Toussirot E; Vauchy C; Binda D; Michel F
Drug Des Devel Ther; 2016; 10():2087-94. PubMed ID: 27445459
[TBL] [Abstract][Full Text] [Related]
5. Golimumab for the treatment of axial spondyloarthritis.
Palazzi C; D'angelo S; Gilio M; Leccese P; Padula A; Olivieri I
Expert Opin Biol Ther; 2017 Jan; 17(1):129-133. PubMed ID: 27817204
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.
Ciurea A; Scherer A; Exer P; Bernhard J; Dudler J; Beyeler B; Kissling R; Stekhoven D; Rufibach K; Tamborrini G; Weiss B; Müller R; Nissen MJ; Michel BA; van der Heijde D; Dougados M; Boonen A; Weber U;
Arthritis Rheum; 2013 Dec; 65(12):3096-106. PubMed ID: 23983141
[TBL] [Abstract][Full Text] [Related]
7. Brief Report: Clinical Course Over Two Years in Patients With Early Nonradiographic Axial Spondyloarthritis and Patients With Ankylosing Spondylitis Not Treated With Tumor Necrosis Factor Blockers: Results From the German Spondyloarthritis Inception Cohort.
Poddubnyy D; Haibel H; Braun J; Rudwaleit M; Sieper J
Arthritis Rheumatol; 2015 Sep; 67(9):2369-75. PubMed ID: 26017497
[TBL] [Abstract][Full Text] [Related]
8. Editorial review: how early should ankylosing spondylitis be treated with a tumor necrosis factor-blocker?
Haibel H; Sieper J
Curr Opin Rheumatol; 2010 Jul; 22(4):388-92. PubMed ID: 20473176
[TBL] [Abstract][Full Text] [Related]
9. Similarities and differences between nonradiographic and radiographic axial spondyloarthritis: a clinical, epidemiological and therapeutic assessment.
Poddubnyy D; Sieper J
Curr Opin Rheumatol; 2014 Jul; 26(4):377-83. PubMed ID: 24807404
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritis.
Sieper J; van der Heijde D; Dougados M; Maksymowych WP; Scott BB; Boice JA; Berd Y; Bergman G; Curtis S; Tzontcheva A; Huyck S; Weng HH
Arthritis Rheumatol; 2015 Oct; 67(10):2702-12. PubMed ID: 26139307
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatment.
Appel H; Janssen L; Listing J; Heydrich R; Rudwaleit M; Sieper J
Arthritis Res Ther; 2008; 10(5):R125. PubMed ID: 18945353
[TBL] [Abstract][Full Text] [Related]
12. Tumor Necrosis Factor-α Inhibition in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Treatment Response, Drug Survival, and Patient Outcome.
Corli J; Flipo RM; Philippe P; Bera-Louville A; Béhal H; Wibaux C; Paccou J
J Rheumatol; 2015 Dec; 42(12):2376-82. PubMed ID: 26568593
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.
Callhoff J; Sieper J; Weiß A; Zink A; Listing J
Ann Rheum Dis; 2015 Jun; 74(6):1241-8. PubMed ID: 24718959
[TBL] [Abstract][Full Text] [Related]
14. The Sex Influence on Response to Tumor Necrosis Factor-α Inhibitors and Remission in Axial Spondyloarthritis.
Lubrano E; Perrotta FM; Manara M; D'Angelo S; Addimanda O; Ramonda R; Punzi L; Olivieri I; Salvarani C; Marchesoni A
J Rheumatol; 2018 Feb; 45(2):195-201. PubMed ID: 29419448
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis - a five-year update.
Poddubnyy D; Rudwaleit M
Expert Opin Biol Ther; 2013 Nov; 13(11):1599-611. PubMed ID: 24074224
[TBL] [Abstract][Full Text] [Related]
16. How to treat ankylosing spondylitis and nonradiographic axial spondyloarthritis. Key practical messages from the 2015 American College of Rheumatology recommendations.
Uthman I; Noureldine MH; Arayssi T; Chalhoub NE; Akl EA
Pol Arch Med Wewn; 2016 Mar; 126(4):254-61. PubMed ID: 27025863
[TBL] [Abstract][Full Text] [Related]
17. Golimumab: Review of the efficacy and tolerability of a recently approved tumor necrosis factor-α inhibitor.
Boyce EG; Halilovic J; Stan-Ugbene O
Clin Ther; 2010 Sep; 32(10):1681-703. PubMed ID: 21194591
[TBL] [Abstract][Full Text] [Related]
18. Biologics in spondyloarthritis: TNFα inhibitors and other agents.
Toussirot É
Immunotherapy; 2015; 7(6):669-81. PubMed ID: 26058432
[TBL] [Abstract][Full Text] [Related]
19. Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study.
Lubrano E; Perrotta FM; Marchesoni A; D'Angelo S; Ramonda R; Addimanda O; Olivieri I; Punzi L; Salvarani C
J Rheumatol; 2015 Feb; 42(2):258-63. PubMed ID: 25512483
[TBL] [Abstract][Full Text] [Related]
20. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.
Ward MM; Deodhar A; Akl EA; Lui A; Ermann J; Gensler LS; Smith JA; Borenstein D; Hiratzka J; Weiss PF; Inman RD; Majithia V; Haroon N; Maksymowych WP; Joyce J; Clark BM; Colbert RA; Figgie MP; Hallegua DS; Prete PE; Rosenbaum JT; Stebulis JA; van den Bosch F; Yu DT; Miller AS; Reveille JD; Caplan L
Arthritis Rheumatol; 2016 Feb; 68(2):282-98. PubMed ID: 26401991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
